United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72162-1813_e8a268d7-a080-4540-8ac9-63201fd965e4
- Product NDC
- 72162-1813
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091124
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (72162-1813-1) · 72162-1813-1
- 120 CAPSULE in 1 BOTTLE (72162-1813-2) · 72162-1813-2
- 20 CAPSULE in 1 BOTTLE (72162-1813-4) · 72162-1813-4
- 60 CAPSULE in 1 BOTTLE (72162-1813-6) · 72162-1813-6
- 180 CAPSULE in 1 BOTTLE (72162-1813-7) · 72162-1813-7
- 84 CAPSULE in 1 BOTTLE (72162-1813-8) · 72162-1813-8
- 90 CAPSULE in 1 BOTTLE (72162-1813-9) · 72162-1813-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →